New diabetes clinical trial: The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria

Published on: September 24, 2024 at 11:00PM
Conditions: Urine Albumin (UAlb); Glycocalyx; Arterial Stiffness
Interventions: Drug: Dulaglutide; Drug: DPP-4 Inhibitors
Sponsors: Attikon Hospital
Active, not recruiting
https://ift.tt/P25g9ZV